Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis

Table 1 Correlation between each neutrophil-to-lymphocyte ratio cut-off and overall survival of hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis using the Kaplan-Meier method

Cut-off value	Group	Cases	1-yr OS	2-yr OS	3-yr OS	5-yr OS	χ2	P value
1.0	NLR ≤ 1 vs > 1	5 vs 76	80.0% vs 46.9%	40.0% vs 27.7%	40.0% vs 19.0%	0.0% vs 17.3%	0.272	0.602
1.5	NLR ≤ 1.5 vs > 1.5	16 vs 65	80.0% vs 41.5%	46.7% vs 24.2%	26.7% vs 19.8%	6.7% vs 19.8%	1.575	0.210
2.0	NLR ≤ 2 vs > 2	28 vs 53	72.3% vs 37.3%	44.2% vs 20.7%	28.1% vs 17.8%	16.1% vs 17.8%	3.657	0.056
2.5	NLR ≤ 2.5 vs > 2.5	39 vs 42	64.5% vs 35.1%	39.2% vs 18.9%	25.2% vs 18.9%	16.8% vs 18.9%	3.935	0.047
2.6	NLR ≤ 2.6 vs > 2.6	42 vs 39	62.1% vs 35.4%	38.5% vs 17.7%	24.7% vs 17.7%	16.5% vs 17.7%	3.987	0.046
2.7	NLR ≤ 2.7 vs > 2.7	44 vs 37	59.1% vs 37.3%	36.6% vs 18.7%	23.6% vs 18.7%	15.7% vs 18.7%	2.254	0.133
2.8	NLR ≤ 2.8 vs > 2.8	49 vs 32	60.2% vs 32.7%	39.1% vs 13.1%	26.1% vs 13.1%	18.3% vs 13.1%	6.007	0.014
2.9	NLR ≤ 2.9 vs > 2.9	51 vs 30	59.8% vs 31.5%	39.5% vs 10.5%	26.3% vs 10.5%	18.4% vs 10.5%	7.227	0.007
3.0	NLR ≤ 3 vs > 3	53 vs 28	59.8% vs 32.1%	38.8% vs 10.7%	25.9% vs 10.7%	18.1% vs 10.7%	6.158	0.013
3.5	NLR ≤ 3.5 vs > 3.5	62 vs 19	56.7% vs 26.3%	34.4% vs 10.5%	23.7% vs 10.5%	17.2% vs 10.5%	2.843	0.092
4.0	NLR ≤ 4 vs > 4	66 vs 15	56.2% vs 20.0%	33.8% vs 6.7%	23.9% vs 6.7%	17.9% vs 6.7%	5.284	0.022
4.5	NLR ≤ 4.5 vs > 4.5	72 vs 9	51.1% vs 33.3%	30.7% vs 11.1%	21.7% vs 11.1%	16.3% vs 11.1%	1.724	0.189
5.0	NLR ≤ 5 vs > 5	75 vs 6	50.3% vs 33.3%	29.4% vs 16.7%	20.7% vs 16.7%	15.6% vs 16.7%	0.527	0.468